Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 1, 2016, Pages 301-304

  Guttman Yassky, Emma ^a,b   Ungar, Benjamin ^a,b   Noda, Shinji ^b   Suprun, Maria ^a   Shroff, Anjali ^a   Dutt, Riana ^a   Khattri, Saakshi ^a   Min, Michelle ^a   Mansouri, Yasaman ^a   Zheng, Xiuzhong ^b   Estrada, Yeriel D ^a   Singer, Giselle K ^a   Suarez Farinas, Mayte ^a,b   Krueger, James G ^b   Lebwohl, Mark G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 PROTEIN; CD1B ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 23P19; INTERLEUKIN 23P40; KERATIN; MACROPHAGE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 4; STAT1 PROTEIN; UNCLASSIFIED DRUG; USTEKINUMAB;

ALOPECIA; ALOPECIA AREATA; ALOPECIA UNIVERSALIS; ATOPIC DERMATITIS; CLINICAL ARTICLE; DRUG EFFICACY; GENE EXPRESSION; HAIR GROWTH; HAIR LOSS; HUMAN; HUMAN TISSUE; LETTER; MEDICAL PHOTOGRAPHY; PRIORITY JOURNAL; PSORIASIS; SCALP; SKIN BIOPSY; ADULT; ANTAGONISTS AND INHIBITORS; CASE REPORT; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; YOUNG ADULT;

ADULT; ALOPECIA AREATA; FEMALE; HUMANS; INTERLEUKIN-12; MALE; MIDDLE AGED; USTEKINUMAB; YOUNG ADULT;

EID: 84953638213     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.11.001     Document Type: Article

References (9)

1. A. Tosti, S. Bellavista, and M. Iorizzo Alopecia areata: a long term follow-up study of 191 patients J Am Acad Dermatol 55 2006 438 441
2. G. Acikgoz, E. Caliskan, M. Tunca, Y. Yeniay, and A. Akar The effect of oral cyclosporine in the treatment of severe alopecia areata Cutan Ocul Toxicol 33 2014 247 252
3. K.Y. Park, W.S. Jang, I.P. Son, S.Y. Choi, M.Y. Lee, B.J. Kim, and et al. Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design Ann Dermatol 25 2013 12 16
4. S. Noda, J.G. Krueger, and E. Guttman-Yassky The translational revolution and use of biologics in patients with inflammatory skin diseases J Allergy Clin Immunol 135 2015 324 336
5. M. Suarez-Farinas, B. Ungar, S. Noda, A. Shroff, Y. Mansouri, J. Fuentes-Duculan, and et al. Alopecia areata profiling shows Th1, Th2, and IL-23 cytokine activation without parallel Th17/Th22 skewing J Allergy Clin Immunol 136 2015 1277 1287
6. L. Xing, Z. Dai, A. Jabbari, J.E. Cerise, C.A. Higgins, W. Gong, and et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition Nat Med 20 2014 1043 1049
7. E. Lee, H.Y. Chuang, J.W. Kim, T. Ideker, and D. Lee Inferring pathway activity toward precise disease classification PLoS Comput Biol 4 2008 e1000217
8. G. Vahedi, Y. Kanno, Y. Furumoto, K. Jiang, S.C. Parker, M.R. Erdos, and et al. Super-enhancers delineate disease-associated regulatory nodes in T cells Nature 520 2015 558 562
9. E. Volpe, L. Pattarini, C. Martinez-Cingolani, S. Meller, M.H. Donnadieu, S.I. Bogiatzi, and et al. Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis J Allergy Clin Immunol 134 2014 373 381